CClinicalTrials.gg
Status unknownNCT04245124VoCET-mTBIUpdated Feb 3, 2021

Validation of Cognitive Enhancement Techniques for Mild Traumatic Brain Injury

An interventional study of Strategic Memory Advanced Reasoning Training and Traditional Cognitive Rehabilitation in Mild Traumatic Brain Injury, sponsored by The Defense and Veterans Brain Injury Center. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2021-02-03.

Sponsored by The Defense and Veterans Brain Injury Center · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
162
Allocation
Randomized
Sex
All
01

Study summary

With an average of 21,000 diagnosed brain injuries each year among military personnel, traumatic brain injury (TBI) remains a major health concern for the United States Military Health System. Mild traumatic brain injury (mTBI) is the most common type of brain injury sustained by military personnel and may result in chronic cognitive impairment.Unfortunately, many service members (SMs) have a history of multiple head injuries as well as psychological co-morbidities that negatively influence recovery. Advances in treatment options for cognitive rehabilitation following mTBI have been of increasing interest to the medical community and may increase treatment efficacy for injured SMs to ensure force readiness.

Cognitive Rehabilitation (CR) for severe brain injury focuses on compensatory strategies for activities of daily living such as using lists to remember grocery items or reminders to take medications and attend medical appointments. Research has shown CR interventions to have considerable effectiveness in the acute and sub-acute phase of recovery after severe TBI. But there is insufficient evidence that they improve rates of individuals returning to work, independence in activities of daily living (ADL), community re-integration, or quality of life.

Read the detailed description

Cognitive Rehabilitation for mild brain injury has shown some modest evidence of effectiveness. CR interventions for mTBI typically focus on compensating for subjective and functional cognitive complaints. A number of recent studies have examined the use of compensatory CR approaches for individuals (primarily military veterans) diagnosed with mild cognitive impairment from a likely mTBI. These interventions taught individuals adaptive functional skills (e.g., cognitive mnemonics) and highlighted use of external aids such as smart phone scheduling/reminder applications. A randomized control trial that included 16 veterans with TBI (mixed mild and moderate severity), found this compensatory CR intervention was effective at reducing overall symptoms, but did not impact cognitive performance or work-outcomes. In a secondary study, there was some evidence that the compensatory CR intervention improved memory at 6 months post-treatment and quality of life at 12 months but there was not a consistent pattern of improvement compared to controls.

Generalizability from civilian and veteran communities to active duty SMs may pose some unique and unexplored factors as the goal of treatment is not remediation of common activities of daily living (e.g., remembering appointments) but in contrast, the goal is military readiness needed for worldwide deployability to potential wartime environments (e.g., "cognitive readiness").

02

Conditions studied

  • Mild Traumatic Brain Injury

Keywords

  • COGNITIVE REHABILITATION
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 384 are open to participants now.

This study's planned enrollment of 162 is above the median of 48 across 1,331 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

The Defense and Veterans Brain Injury Center is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

    • Male or female ages 18 years or older

      • Active duty military personnel
      • History of mTBI: participants will have a history of at least one mTBI sustained >3 months previously based on criteria of the DoD diagnostic criteria (Department of Veterans Affairs and Department of Defense, 2016). This specifies an external force to the head which resulted in physiological dysfunction of the brain as manifested by one or more of the following acute symptoms:

        1. Any loss of consciousness (not to exceed 30 minutes)
        2. Any loss of memory for the events immediately before or after the injury (not to exceed 1 day)
        3. Any alteration of consciousness or change in mental state (not to exceed 24 hours)
      • Persistent Post-Concussive Symptoms: Participants will endorse elevated neurobehavioral symptomatology compared to published normative data (Soble et al. 2014), with at least one cognitive symptom (e.g., a score of 3 or greater on at least one of the four items on the NSI cognitive domain).

Exclusion criteria

Exclusion Criteria:

    • History of TBI (any severity) within 3 months of enrollment.

      • History of moderate, severe, or penetrating TBI as defined by DOD/VA guidelines during their lifetime
      • Current substance use disorder based on patient self-report.
      • History of a neurological disease other than mild TBI such as multiple sclerosis, cerebral vascular accident, brain tumor, neurodegenerative disease, or neuro-motor disorder.
      • Current, active suicidal or homicidal ideation.
      • Impaired decision-making capacity.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
162 participants (estimated)

Study arms

  • Experimental
    SMART INTERVENTION

    N= 81 20 HOURS THERAPY IMMEDIATE POST TREATMENT EVALUATION 3 MONTH POST TREATMENT EVALUATION

    Other: Strategic Memory Advanced Reasoning Training

  • Experimental
    TCR

    N= 81 60 HOURS THERAPY IMMEDIATE POST TREATMENT EVALUATION 3 MONTH POST TREATMENT EVALUATION

    Other: Traditional Cognitive Rehabilitation

Interventions

  • OtherStrategic Memory Advanced Reasoning Training

    SMART focuses on three metacognitive strategies: Strategic Attention, Integrated Reasoning and Innovation.

  • OtherTraditional Cognitive Rehabilitation

    Participants randomized to the TCR condition will participate in a clinician-directed intervention that provides manualized, traditional clinician-directed cognitive rehabilitation that was developed for the SCORE trial (Cooper et al., 2017)

06

What researchers measure

Primary outcomes

  1. Change in cognitive impairment

    Cognitive impairment will be measured using the Global Deficit Score (GDS) which allows for the detection of subtle and varied degree of impairment from multiple measures.

    Time frame: 4 MONTHS

Secondary outcomes

  1. Change in healthcare utilization

    Healthcare utilization post-treatment, as measured by the number of medical appointments to rehabilitation specialists.

    Time frame: 4.5 MONTHS

  2. Change in level of occupational performance

    Ratings of occupational performance by a direct supervisor using a modified Checklist of Military Activities of Daily Living (M-ADL).

    Time frame: 4.5 MONTHS

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04245124
Lead sponsor
The Defense and Veterans Brain Injury Center
Collaborators
The University of Texas at Dallas
Responsible party
Sponsor
First posted
Jan 28, 2020
Start date
Feb 1, 2021 (estimated)
Primary completion
Sep 30, 2024 (estimated)
Completion
Sep 30, 2024 (estimated)
Last update
Feb 3, 2021

Study contacts

Angela G Basham, MPH
Contact
ANGELA.G.BASHAM.CTR@MAIL.MIL
7607194201
MELISSA JENSEN
Contact
melissa.a.jensen16.ctr@mail.mil

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion